Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Ehrenstein

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Nature Reviews. Rheumatology|September 3, 2010
The yin and yang of regulatory T cells and inflammation in RAClare A Notley, Michael R Ehrenstein
The Journal of Experimental Medicine|January 4, 2007
Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-betaSuchita Nadkarni, Claudia Mauri, Michael R Ehrenstein
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2010
Secreted IgM enhances B cell receptor signaling and promotes splenic but impairs peritoneal B cell survivalClare A Notley, Nicole Baker, Michael R Ehrenstein
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2015
Cutting edge: circulating plasmablasts induce the differentiation of human T follicular helper cells via IL-6 productionKonstantia-Maria Chavele, Eve Merry, Michael R Ehrenstein
European Journal of Immunology|April 9, 2008
Restoring the balance: harnessing regulatory T cells for therapy in rheumatoid arthritisFabian Flores-Borja, Claudia Mauri, Michael R Ehrenstein
Springer Seminars in Immunopathology|December 22, 2004
Natural serum IgM maintains immunological homeostasis and prevents autoimmunityJessica J Manson, Claudia Mauri, Michael R Ehrenstein
The Lancet. Rheumatology|March 9, 2025
Evolution and trajectory of B-cell targeted therapies in rheumatic diseasesLucy Marie Carter, Michael R Ehrenstein, Edward M Vital
Seminars in Immunology|September 2, 2011
Therapeutic potential of Tregs to treat rheumatoid arthritisGraham P Wright, Hans J Stauss, Michael R Ehrenstein
Expert Review of Clinical Immunology|March 24, 2011
Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunityGraham P Wright, Michael R Ehrenstein, Hans J Stauss
Arthritis and Rheumatism|July 11, 2013
Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosusLucy M Carter, David A Isenberg, Michael R Ehrenstein
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Nature Reviews. Rheumatology|September 3, 2010
The yin and yang of regulatory T cells and inflammation in RAClare A Notley, Michael R Ehrenstein
The Journal of Experimental Medicine|January 4, 2007
Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-betaSuchita Nadkarni, Claudia Mauri, Michael R Ehrenstein
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2010
Secreted IgM enhances B cell receptor signaling and promotes splenic but impairs peritoneal B cell survivalClare A Notley, Nicole Baker, Michael R Ehrenstein
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2015
Cutting edge: circulating plasmablasts induce the differentiation of human T follicular helper cells via IL-6 productionKonstantia-Maria Chavele, Eve Merry, Michael R Ehrenstein
European Journal of Immunology|April 9, 2008
Restoring the balance: harnessing regulatory T cells for therapy in rheumatoid arthritisFabian Flores-Borja, Claudia Mauri, Michael R Ehrenstein
Springer Seminars in Immunopathology|December 22, 2004
Natural serum IgM maintains immunological homeostasis and prevents autoimmunityJessica J Manson, Claudia Mauri, Michael R Ehrenstein
The Lancet. Rheumatology|March 9, 2025
Evolution and trajectory of B-cell targeted therapies in rheumatic diseasesLucy Marie Carter, Michael R Ehrenstein, Edward M Vital
Seminars in Immunology|September 2, 2011
Therapeutic potential of Tregs to treat rheumatoid arthritisGraham P Wright, Hans J Stauss, Michael R Ehrenstein
Expert Review of Clinical Immunology|March 24, 2011
Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunityGraham P Wright, Michael R Ehrenstein, Hans J Stauss
Arthritis and Rheumatism|July 11, 2013
Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosusLucy M Carter, David A Isenberg, Michael R Ehrenstein
Pageof 7